Oncolytics Biotech Inc.

ONCY · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$12,352$14,626$15,303$15,942
Short-Term Investments$0$0$0$0
Receivables$54$72$89$68
Inventory$0$0$0$0
Other Curr. Assets$0$1,024$1,220$980
Total Curr. Assets$14,051$18,896$18,487$18,875
Property Plant & Equip (Net)$1,006$1,078$1,215$1,312
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,006$1,078$1,215$1,312
Other Assets$0$0$0$0
Total Assets$15,057$19,974$19,702$20,187
Liabilities
Payables$4,201$1,331$779$1,087
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$199$982$530$1,618
Total Curr. Liab.$7,655$6,558$5,768$6,687
LT Debt$0$0$0$0
Deferred Rev, NC$6,730$6,730$6,730$6,730
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$7,287$7,327$7,440$7,517
Other Liabilities$0$0$0$0
Cap. Leases$835$888$1,000$1,064
Total Liabilities$14,942$13,885$13,208$14,204
Equity
Pref Stock$0$0$0$0
Common Stock$458,630$451,142$445,533$438,193
Retained Earnings-$504,965-$490,565-$484,400-$477,713
AOCI$789$720$958$961
Other Equity$0$0$0$0
Total Equity$115$6,089$6,494$5,983
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,057$19,974$19,702$20,187
Net Debt-$12,352-$14,626-$15,303-$15,942